Literature DB >> 22902408

Comparison between CT volume measurement and histopathological assessment of response to neoadjuvant therapy in rectal cancer.

Fabio Pomerri1, Salvatore Pucciarelli, Gisella Gennaro, Isacco Maretto, Donato Nitti, Pier Carlo Muzzio.   

Abstract

OBJECTIVES: The aim of this study was to compare volume measurements on computed tomography (CT) images with histopathological assessments of chemoradiotherapy (CRT)-induced tumor regression in locally advanced rectal cancer (RC).
METHODS: In 25 patients (13 males, 12 females; median age, 63 years; age range, 44-79 years) with locally advanced RC treated with preoperative CRT and surgery, two radiologists measured tumor volume on CT images before and after CRT. CT-based tumor volumetry and the modified response evaluation criteria in solid tumors (mRECISTs) were compared with T and N downstaging after CRT, and with the tumor regression grade (TRG).
RESULTS: Tumor volumes were significantly smaller on CT images after CRT. The tumors regressed in 52% (13/25), 36% (9/25) and 40% (10/25) of patients, based on T downstaging, TRG and mRECIST findings, respectively. In terms of T downstaging, the pre- and post-CRT tumor volumes of responders and non-responders to the treatment differed statistically, while their tumor volume reduction rates and volume reductions according to the 65% mRECIST threshold did not. In terms of N downstaging and TRG, the differences between the responders' and the non-responders' pre- and post-CRT tumor volumes, tumor volume reduction rates, and mRECIST thresholds were never statistically significant.
CONCLUSION: Measuring tumor size on CT images is of limited value in predicting the histopathological response to preoperative CRT in RC patients, so it may be unwise to select surgical treatment strategies based on CT volumetry.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22902408     DOI: 10.1016/j.ejrad.2012.04.038

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  6 in total

1.  Decreased ERCC1 Expression After Platinum-Based Neoadjuvant Chemotherapy in non-Small Cell Lung Cancer.

Authors:  Eszter Podmaniczky; Katalin Fábián; Judit Pápay; Rita Puskás; Márton Gyulai; József Furák; László Tiszlavicz; György Losonczy; József Tímár; Judit Moldvay
Journal:  Pathol Oncol Res       Date:  2014-09-07       Impact factor: 3.201

Review 2.  Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging.

Authors:  Pier Paolo Mainenti; Arnaldo Stanzione; Salvatore Guarino; Valeria Romeo; Lorenzo Ugga; Federica Romano; Giovanni Storto; Simone Maurea; Arturo Brunetti
Journal:  World J Gastroenterol       Date:  2019-09-21       Impact factor: 5.742

3.  T2-weighted, apparent diffusion coefficient and 18F-FDG PET histogram analysis of rectal cancer after preoperative chemoradiotherapy.

Authors:  F Crimì; R Stramare; G Spolverato; V Aldegheri; A Barison; L D'Alimonte; Q R Bao; A Spimpolo; L Albertoni; D Cecchin; C Campi; E Quaia; S Pucciarelli; P Zucchetta
Journal:  Tech Coloproctol       Date:  2021-04-01       Impact factor: 3.781

4.  Imaging for guiding a more tailored approach in rectal cancer patients.

Authors:  Gaya Spolverato; Filippo Crimì; Salvatore Pucciarelli
Journal:  Ann Transl Med       Date:  2022-08

5.  The predictive value of tumor volume reduction ratio on three-dimensional endorectal ultrasound for tumor response to chemoradiotherapy for locally advanced rectal cancer.

Authors:  Limei Chen; Xiaoyin Liu; Wenjing Zhang; Si Qin; Yimin Wang; Jing Lin; Qiu Chen; Guangjian Liu
Journal:  Ann Transl Med       Date:  2022-06

6.  Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy.

Authors:  Abhishek A Solanki; Daniel T Chang; Stanley L Liauw
Journal:  Onco Targets Ther       Date:  2013-08-14       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.